Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other Accumulated Expenses (2017 - 2021)

Cogent Biosciences has reported Other Accumulated Expenses over the past 4 years, most recently at $225000.0 for Q3 2021.

  • Quarterly results put Other Accumulated Expenses at $225000.0 for Q3 2021, changed N/A from a year ago — trailing twelve months through Sep 2021 was $225000.0 (changed N/A YoY), and the annual figure for FY2020 was $307000.0, changed.
  • Other Accumulated Expenses for Q3 2021 was $225000.0 at Cogent Biosciences, down from $1.1 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for COGT hit a ceiling of $2.0 million in Q3 2018 and a floor of $180000.0 in Q4 2017.
  • Median Other Accumulated Expenses over the past 4 years was $271000.0 (2020), compared with a mean of $649000.0.